Hematology
From the Journals
Reversal agents curb DOAC-related bleeding but deaths still high
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
From the Journals
Elevated factor VIII troughs can lead to a higher proportion of zero bleeds in hemophilia
Feature
Medical homes a boon to patients with bleeding disorders
News
FDA approves new treatment option for rare anemia
Pegcetacoplan (Empaveli) was approved as a treatment for paroxysmal nocturnal hemoglobinuria (PNH).
Conference Coverage
Omics analysis links blood type to COVID-19
From the Journals
Patients with CLL have significantly reduced response to COVID-19 vaccine
Less than half of CLL patients had an antibody-mediated response to the Pfizer vaccine in a study.
From the Journals
Health costs over 25 times higher for hemophilia B patients than controls
Conference Coverage
Pediatric cancer survivors at risk for opioid misuse
From the Journals
High variability found in studies assessing hemophilia-related pain
From the Journals
AHA guidance on blood clots linked to COVID-19 vaccine
Commentary
Commentary: Functional assessment developed for older adults with sickle cell disease